{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:00:47Z","timestamp":1787065247373,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.exphem.2013.03.007","type":"journal-article","created":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T14:48:35Z","timestamp":1364482115000},"page":"627-634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Telomere shortening in Ph-negative chronic myeloproliferative neoplasms: A biological marker of polycythemia vera and myelofibrosis, regardless of\u00a0hydroxycarbamide therapy"],"prefix":"10.1016","volume":"41","author":[{"given":"Marco","family":"Ruella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Salmoiraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Risso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Carobbio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Buttiglieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Spatola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piera","family":"Sivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Ricca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziano","family":"Barbui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Tarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rambaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2013.03.007_bib1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/350569a0","article-title":"Structure and function of telomeres","volume":"350","author":"Blackburn","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2013.03.007_bib2","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1126\/science.270.5242.1601","article-title":"Telomeres: beginning to understand the end","volume":"270","author":"Zakian","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.exphem.2013.03.007_bib3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0092-8674(00)80932-0","article-title":"TRF2 protects human telomeres from end-to-end fusions","volume":"92","author":"van Steensel","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2013.03.007_bib4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0092-8674(00)80760-6","article-title":"Mammalian telomeres end in a large duplex loop","volume":"97","author":"Griffith","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2013.03.007_bib5","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood-2007-09-084913","article-title":"Telomeres, stem cells, and hematology","volume":"111","author":"Lansdorp","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.03.007_bib6","first-page":"518","article-title":"Structure and variability of human chromosome ends","volume":"10","author":"de Lange","year":"1990","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2013.03.007_bib7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/excr.2000.4823","article-title":"Accumulation of short telomeres in human fibroblasts prior to replicative senescence","volume":"256","author":"Martens","year":"2000","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.exphem.2013.03.007_bib8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/bies.950120803","article-title":"Telomeres, telomerase and senescence","volume":"12","author":"Greider","year":"1990","journal-title":"Bioessays"},{"key":"10.1016\/j.exphem.2013.03.007_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0921-8734(91)90018-7","article-title":"Telomere loss: Mitotic clock or genetic time bomb?","volume":"256","author":"Harley","year":"1991","journal-title":"Mutat Res"},{"key":"10.1016\/j.exphem.2013.03.007_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0921-8734(91)90032-7","article-title":"In\u00a0vivo loss of telomeric repeats with age in humans","volume":"256","author":"Lindsey","year":"1991","journal-title":"Mutat Res"},{"key":"10.1016\/j.exphem.2013.03.007_bib11","doi-asserted-by":"crossref","first-page":"10114","DOI":"10.1073\/pnas.89.21.10114","article-title":"Telomere length predicts replicative capacity of human fibroblasts","volume":"89","author":"Allsopp","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2013.03.007_bib12","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/346866a0","article-title":"Telomere reduction in human colorectal carcinoma and with ageing","volume":"346","author":"Hastie","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2013.03.007_bib13","first-page":"661","article-title":"Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes","volume":"52","author":"Vaziri","year":"1993","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.exphem.2013.03.007_bib14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s004320000137","article-title":"Telomere shortening in gastric carcinoma with aging despite telomerase activation","volume":"126","author":"Furugori","year":"2000","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.exphem.2013.03.007_bib15","first-page":"307","article-title":"Telomere length and hTERT expression in patients with acute myeloid leukemia correlates with chromosomal abnormalities","volume":"90","author":"Hartmann","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2013.03.007_bib16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/10428190400018349","article-title":"Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia","volume":"46","author":"Kubuki","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2013.03.007_bib17","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/sj.leu.2403596","article-title":"Telomeres and telomerase in paediatric patients with T-cell acute lymphoblastic leukaemia (T-ALL)","volume":"19","author":"Kleideiter","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2013.03.007_bib18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0165-4608(94)90047-7","article-title":"Telomere shortening in leukemic cells is related to their genetic alterations but not replicative capability","volume":"78","author":"Ohyashiki","year":"1994","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.exphem.2013.03.007_bib19","first-page":"1155","article-title":"Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes","volume":"5","author":"Ohyashiki","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2013.03.007_bib20","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/sj.leu.2404544","article-title":"Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients","volume":"21","author":"Ricca","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2013.03.007_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/hon.937","article-title":"Telomeres and telomerase in normal and malignant B-cells","volume":"28","author":"Lobetti-Bodoni","year":"2010","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.exphem.2013.03.007_bib22","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1158\/1055-9965.EPI-11-0005","article-title":"The association of telomere length and cancer: a meta-analysis","volume":"20","author":"Wentzensen","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.exphem.2013.03.007_bib23","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.exphem.2007.03.009","article-title":"Short telomeres in aggressive non-Hodgkin's lymphoma as a risk factor in lymphomagenesis","volume":"35","author":"Widmann","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2013.03.007_bib24","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1182\/blood.V96.1.358","article-title":"Telomere length shortening in chronic myelogenous leukemia is associated with reduced time to accelerated phase","volume":"96","author":"Boultwood","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.03.007_bib25","first-page":"610","article-title":"Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex\u00a0vivo culture","volume":"60","author":"Engelhardt","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2013.03.007_bib26","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0301-472X(02)00969-4","article-title":"Accelerated telomere length shortening in granulocytes: a diagnostic marker for myeloproliferative diseases","volume":"30","author":"Terasaki","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2013.03.007_bib27","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1593\/neo.09836","article-title":"Individual telomere lengths in chronic myeloid leukemia","volume":"11","author":"Samassekou","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.exphem.2013.03.007_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hon.901","article-title":"Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapy","volume":"27","author":"Keller","year":"2009","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.exphem.2013.03.007_bib29","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1080\/10428190410001693542","article-title":"Telomere shortening correlates with prognostic score at diagnosis and proceeds rapidly during progression of chronic myeloid leukemia","volume":"45","author":"Drummond","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2013.03.007_bib30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood-2002-08-2557","article-title":"Telomere length in peripheral blood granulocytes reflects response to treatment with imatinib in patients with chronic myeloid leukemia","volume":"101","author":"Brummendorf","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.03.007_bib31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/10428190009054880","article-title":"Telomere dynamics and genetic instability in disease progression of chronic myeloid leukemia","volume":"40","author":"Ohyashiki","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2013.03.007_bib32","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/sj.leu.2404339","article-title":"Telomere length dynamics in normal hematopoiesis and in disease states characterized by increased stem cell turnover","volume":"20","author":"Brummendorf","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2013.03.007_bib33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/leu.2008.319","article-title":"Telomere length is severely and similarly reduced in JAK2V617F-positive and -negative myeloproliferative neoplasms","volume":"23","author":"Bernard","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2013.03.007_bib34","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1182\/blood-2004-06-2375","article-title":"High telomerase activity in granulocytes from clonal polycythemia vera and essential thrombocythemia","volume":"105","author":"Ferraris","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.03.007_bib35","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.leukres.2010.07.042","article-title":"Dynamics of telomere's length and telomerase activity in Philadelphia chromosome negative myeloproliferative neoplasms","volume":"35","author":"Spanoudakis","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2013.03.007_bib36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/bmt.2009.297","article-title":"Comparative assessment of telomere length before and after hematopoietic SCT: role of grafted cells in determining post-transplant telomere status","volume":"45","author":"Ruella","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2013.03.007_bib37","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1093\/nar\/26.16.3651","article-title":"Telomere analysis by fluorescence in situ hybridization and flow cytometry","volume":"26","author":"Hultdin","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2013.03.007_bib38","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1182\/blood-2011-11-390351","article-title":"Methylation of AR locus does not always reflect X chromosome inactivation state","volume":"119","author":"Swierczek","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.03.007_bib39","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1182\/blood-2008-12-195677","article-title":"Skewing of X-inactivation ratios in blood cells of aging women is confirmed by independent methodologies","volume":"113","author":"Busque","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.03.007_bib40","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2013.03.007_bib41","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/sj.leu.2405049","article-title":"The histone deacetylase inhibitor ITF2357 selectively targets cells bearing mutated JAK2(V617F)","volume":"22","author":"Guerini","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2013.03.007_bib42","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1038\/sj.leu.2404810","article-title":"Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera","volume":"21","author":"Pardanani","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2013.03.007_bib43","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2141.2005.05618.x","article-title":"Clonal granulocytes in polycythaemia vera and essential thrombocythaemia have shortened telomeres","volume":"130","author":"Ferraris","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2013.03.007_bib44","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3324\/haematol.2011.047803","article-title":"Flow-FISH evaluation of telomere length in Philadelphia-negative myeloproliferative neoplasms","volume":"96","author":"Elena","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2013.03.007_bib45","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1200\/JCO.2010.31.8436","article-title":"Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet","volume":"29","author":"Barbui","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2013.03.007_bib46","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.semcancer.2011.10.001","article-title":"Role of telomeres and telomerase in cancer","volume":"21","author":"Shay","year":"2011","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.exphem.2013.03.007_bib47","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1200\/JCO.2011.36.0792","article-title":"Treatment of polycythemia vera with hydroxyurea and pipobroman: final results of a randomized trial initiated in 1980","volume":"29","author":"Kiladjian","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2013.03.007_bib48","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1200\/JCO.2011.34.7542","article-title":"Treatment-related risk\u00a0factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms","volume":"29","author":"Bjorkholm","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2013.03.007_bib49","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMoa1002028","article-title":"Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis","volume":"363","author":"Verstovsek","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.exphem.2013.03.007_bib50","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1200\/JCO.2010.32.8021","article-title":"Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosis","volume":"29","author":"Pardanani","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2013.03.007_bib51","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1200\/JCO.2008.17.1033","article-title":"Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma","volume":"27","author":"Chakraborty","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X13001197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X13001197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:30:24Z","timestamp":1759566624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X13001197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0301472X13001197"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2013.03.007","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Telomere shortening in Ph-negative chronic myeloproliferative neoplasms: A biological marker of polycythemia vera and myelofibrosis, regardless of\u00a0hydroxycarbamide therapy","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2013.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}